Quick Answer
VitaNova Life Sciences Corp reported Diluted EPS of $0.03 per share for fiscal year 2025.
VitaNova Life Sciences Corp Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | $0.03 | +200.0% |
| 2024 | $0.01 | — |
| 2023 | $0.00 | -100.0% |
| 2022 | $0.02 | +300.0% |
| 2021 | -$0.01 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| January 31, 2026 | -$0.01 | -200.0% | — |
| October 31, 2025 | $0.00 | — | — |
| July 31, 2025 | $0.00 | — | -100.0% |
| January 31, 2025 | $0.01 | — | — |
| October 31, 2024 | $0.00 | — | — |
| July 31, 2024 | $0.00 | — | — |
| January 31, 2024 | $0.00 | — | — |
| October 31, 2023 | $0.00 | — | — |
- VitaNova Life Sciences Corp showed an increase of +200.0% in Diluted EPS compared to the prior fiscal year.
- Over the 2021–2025 period, VitaNova Life Sciences Corp’s diluted eps has grown by 400.0% (from $0.01 per share (loss) to $0.03 per share).
- The most recent figure is from VitaNova Life Sciences Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on July 24, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: